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To understand how proteins perform their function, knowledge about their structure and
dynamics is essential. Here we use a combination of an efficient chemical lysine acetylation
reaction and nanoLC-MALDI tandem mass spectrometry to probe the accessibility of every
lysine residue in a protein complex. To demonstrate the applicability of this approach, we
studied the interaction between the DNase domain of Colicin E9 (E9) and its immunity protein
Im9. Free E9 and E9 in complex with Im9 were rapidly acetylated, followed by proteolytic
digestion and analysis by LC-MALDI-TOF/TOF MS/MS. Acetylated peptides could be
filtered out of the complex peptide mixtures using selective ion chromatograms of the specific
immonium marker ions. Additionally, isobaric acetylated peptides, acetylated at different
sites, could be separated by their LC retention times. The combination of LC and MALDI-
TOF/TOF MS/MS provided information about the amount of acetylation on each individual
lysine even for peptides containing several lysine residues. In general, our data agree well with
those derived from the crystal structure of E9 and the E9:Im9 complex. Interestingly, next to
in the binding interface expected lysines, K89 and K97, two from the crystal structure data
unexpected lysines, K81 and K76, were observed to become less exposed upon Im9 binding.
Moreover, K55 and K63, positioned in the predicted DNA binding region, were also found to
be less accessible upon Im9 binding. These findings may illustrate some of the described
differences in the solution-phase structure of the E9:Im9 complex compared with the crystal
structure. (J Am Soc Mass Spectrom 2006, 17, 983–994) © 2006 American Society for Mass
SpectrometryHydrogen-Deuterium exchange (HDx) in combi-nation with mass spectrometry is one of themost frequently used methods to probe protein
structure, conformational dynamics and protein–pro-
tein interactions [1]. HDx studies are primarily focused
on the exchange of backbone amide hydrogens, en-
abling the dynamics of exchange to be monitored for
the entire protein. The nonspecificity of D2O helps to
achieve a high coverage and spatial resolution; poten-
tially, the exchange dynamics of each individual amino
acid in the sequence can be monitored. A drawback of
the HDx method is the possible fast back-exchange of
deuterium to hydrogen, which restricts the use of HDx
to short sample preparation times at low-temperature
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doi:10.1016/j.jasms.2006.03.005and pH conditions. To monitor HDx, usually pepsin
digestion at pH 2.8 is used. Since pepsin is a nonspecific
protease, it leads to a large, unpredictable number of
peptide possibilities, complicating data analysis [2, 3].
Additionally, when using tandem mass spectrometry
on the (partly) H/D-exchanged proteolytic peptides,
gas-phase “hydrogen-deuterium scrambling” may
hamper the detailed analysis of amino acid specific
exchange rates [4 –7].
To overcome some of these restrictions, other chem-
ical labeling methods have been developed. Many of
them utilize the reactive primary amine on the side
chain of lysine residues [8 –10]. Since lysine residues are
charged, they are most likely to be present at solvent
accessible regions of proteins, making them ideal can-
didates to probe protein–protein interaction surfaces.
For instance, Przybylski et al. described a method to
probe protein structure by acetylation of lysines using
acetic anhydride [8]. The acetic anhydride targets quite
specifically the acetyl group of lysines, and covalently
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Side reactions on the hydroxyl group of tyrosines have
been reported, but they may be easily reversed under
acidic conditions. Others have also successfully used
acetic anhydride for structure determinations [9, 10].
Recently, several new reagents and labels have emerged
that target solvent accessible lysines: N-hydroxysuccin-
imido-biotin (NHS-biotin) [11, 12], sulfosuccinimidyl
acetate [13] and S-methylthioacetimidate [14]. Espe-
cially, the use of NHS-ester chemistry in lysine labeling
has proven to be efficient and reliable. Compared to
acetic anhydride, the used concentrations are 1000-fold
lower to achieve ample lysine acetylation.
In this work, we chose for N-acetyl-succinimide
(NHS-Ac) as a fast and efficient chemical probe to study
the protein–protein interaction surface of the DNase
domain of Colicin E9 (E9) with its immunity protein
Im9. E9 is a member of a family of bacterial endonucle-
ase colicins that are released by Escherichia coli into the
extracellular medium during times of nutrient or envi-
ronmental stress [15]. The highly toxic 15-kDa C-termi-
nal DNase domain is translocated into the cytoplasm of
the target cell in which it can accomplish its lethal effect
by the hydrolysis of chromosomal DNA [16]. Under
normal conditions, colicin-producing bacteria protect
themselves from suicide by co-expressing a cognate
immunity protein [17]. The toxic 15-kDa C-terminal
DNase domain of E9 forms a tight hetero-dimeric
complex with its cognate 9.5 kDa immunity protein Im9
with a dissociation constant of 1016 M [15, 18]. The
molecular determinants of this strong interaction have
been studied in-depth by X-ray crystallography and
comparative alanine scanning [19]. The DNase domain
can be isolated as an active enzyme [20, 21] and its
structure has been analyzed by X-ray crystallography in
presence and absence of its cognate immunity protein
Im9 [19]. The solution phase structure of free Im9, and
bound to E9, has also been studied by NMR [22]. The
15-kDa C-terminal DNase domain of E9 is able to
coordinate several divalent metal ions within its active
site [20], although it is less clear what the role of the
metal ions is in the DNase activity. It is, however,
known that metal ion binding induces conformational
changes in the E9 protein and stabilizes its structure
[23].
To determine the surface accessibility of a free pro-
tein or one involved in a protein–protein complex, after
a surface labeling method the protein is generally
proteolytically cleaved and the resulting peptides ana-
lyzed by mass spectrometry. For complex peptide mix-
tures, the incorporation of a further liquid chromatog-
raphy (LC) separation step before MS analysis may be
essential. In recent years commercial LC-MALDI inter-
faces have become available. LC-MALDI can be used to
obtain increased proteome coverage by applying the
complementary combination of LC-ESI-MS/MS and
LC-MALDI-MS/MS [24, 25]. Related to this work, Li et
al. used LC-MALDI-MS/MS in combination with iso-
tope labeling and limited enzymatic digestion to mon-itor conformational changes of cardiac troponin C in-
duced by calcium binding [26].
Here we present a combination of chemical lysine
acetylation and LC-MALDI-MS/MS, which we believe
to have intrinsic advantages over LC-ESI-MS/MS. This
is achieved by utilizing the intense specific immonium
ions of acetylated lysine residues (m/z 126.1 Da) under
high-energy collisional activation conditions as present
in MALDI TOF-TOF tandem mass spectrometry [27–
29]. Our study reveals that extracted ion chromato-
grams (EIC) of the marker immonium ions are efficient
tools to filter out acetylated peptides from the very
complex peptide mixtures. We used N-acetyl-succinim-
ide (NHS-Ac) as an efficient chemical probe to study the
protein–protein interaction surface of E9 with its immu-
nity protein Im9. By using the data filtering method
based on the 126.1 Da immonium ions, and LC MALDI
TOF-TOF on all observed acetylated peptides, we were
able to probe each individual lysine residue in the
protein complex.
Experimental
Materials
All chemicals were purchased from commercial sources
and were of analysis grade, unless stated otherwise.
NHS-Ac was synthesized by DCC/DMAP coupling of
acetic acid to N-hydroxysuccinimide and stored under
dry conditions in a dessiccator at room-temperature
(RT). E9 and Im9 were expressed in Escherichia coli and
purified according to Pommer et al. [20]. Endoprotein-
ase Glu-C (V8) and chymotrypsin were purchased from
Roche (Mannheim, Germany). Trifluoroacetic acid
(TFA) was obtained in 1 mL vials from Sigma-Aldrich
(St. Louis, MO), -cyano-4-hydroxycinnamic (CHCA)
acid and sinapinic acid were purchased from Fluka,
(Buchs, Germany). HPLC-S gradient grade acetonitrile
(AcN) was purchased from Biosolve (Valkenswaard,
The Netherlands) and high purity water obtained from
a Milli-Q System (Millipore, Bedford, MA) was used for
all experiments. ZipTip -C18 tips were purchased
from Millipore.
Acetylation of E9 and E9:Im9
Lyophilized E9 and Im9 were dissolved separately in
water, and their concentration was assayed by ab-
sorption at 280 nm. A 2 M solution of E9 was
prepared in 190 L buffer A (100 mM Na2CO3, pH
8.0) in presence or absence of 2 M Im9 and in
presence or absence of 100 M ZnSO4. NHS-Ac was
dissolved in AcN to a concentration of 2 M and
subsequently diluted 10-fold in buffer A. Ten L of
the diluted reagent was added to the E9 solution and
reacted at RT for 3 min (see also Figure 1). The
reaction was allowed to quench for 20 min by addi-
tion of 200 L buffer B (100 mM (NH4)2CO3, pH 8.0).
To ease in solution digestion of E9, the reaction
Spot number
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of 100 L buffer C (100 mM Na2CO3, 25 mM EDTA,
pH 8.0).
Sample Preparation
For MALDI-TOF-MS analysis on intact proteins, 10 L
reaction mixture was acidified by addition of 1% TFA
and applied to a ZipTip. Desalted samples were directly
eluted on the MALDI target with 0.8 L matrix solution
A (5 g L1 sinapinic acid in 80% AcN, 0.1% TFA). For
peptide mass fingerprinting, samples were digested
overnight with a 1:50 protease to E9 mass ratio. V8
digests were performed at RT, chymotrypsin proteoly-
sis was performed at 37 °C. After digestion samples
were stored at 30 °C until analysis. For analysis, 5 L
of acidified peptide mixture was trapped on a ZipTip,
desalted and eluded in 0.8 L matrix solution B (5 g L1
CHCA in 80% AcN, 0.1% TFA) onto the MALDI target.
Instrumental
MALDI-TOF-MS analysis on intact proteins was per-
formed on an Applied Biosystems 4700 Proteomics
analyzer (Framingham, MA) in linear mode, using am/z
5000–25,000 mass range with a focus m/z of 7500.
MALDI-TOF-MS of peptide mixtures was performed
on the same machine in reflectron mode using a m/z
700–5000 Da mass range. Data were acquired at a 200
Hz laser repetition rate, a 20 kV accelerating voltage, a
70% grid voltage and a digitizer bin size of 1.0 ns.
The nanoLC system consisted of a Famos autosam-
pler, an Ultimate nano HPLC system, and a Rheodyne
automated switching nanovalve all from LC Packings
(Amsterdam, The Netherlands). The nanoLC system
was controlled by Chromeleon 6.60 software (Dionex,
Bavel, The Netherlands). A blank MALDI target plate
(Applied Biosystems) was spotted with the LC eluent
using a Probot micro fraction collector (LC Packings)
controlled by Carrier V 1.68 software (Dionex). In the
nanoLC-system two homemade columns were placed: a
100 m i.d./375 m o.d. precolumn of 19 mm filled
with 5 m, 200 Å Aqua C18 stationary phase (Phenome-
nex, Torrance, CA) and a 75 m i.d./360 m o.d.
analytical column of 150 mm filled with the same
material both packed using the procedure described by
Pinkse et al. [30]. In this set-up, connections were made
using two PEEK zero dead-volume T-pieces (Inacom,
Figure 1. Schematic overview of the experiment. E9 and E9:Im9
complex were subjected to selective acetylation with NHS-Ac.
After quenching, the proteins were digested by chymotrypsin or
V8 protease to reach high sequence coverage. Next, the peptides
were separated by nanoLC and spotted onto a MALDI plate. All
spots on the MALDI plate were then analyzed by MALDI-TOF/
TOF. Extra selectivity and sensitivity for peptides that contained
acetylated lysines could be obtained by filtering the data for the
MS/MS product with m/z 126.1, a specific immonium ion ofO
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Packings), and fused silica capillary (75 m i.d./375 m
o.d., Bester, Amstelveen, The Netherlands) except for
the connection between the column and the Probot for
which a fused silica capillary with 20 m i.d./280 m
o.d. was used (LC Packings). The fused silica needle of
the Probot had an i.d. of 30 m (LC Packings). MALDI-
MS(/MS) was performed using a proteomics analyzer
controlled by the 4700 Explorer 3.0 software (Applied
Biosystems).
NanoLC-probot
NanoLC was conducted using the set-up similar to
that described by Meiring et al. [31]. For nanoLC-
MALDI, the set-up depicted in Figure 1 and de-
scribed in the following section was used. Before
injection, 10 L of the sample containing the digest of
E9, acetylated E9 or the acetylated E9:Im9 complex
was acidified with 10 L 1% TFA to allow for optimal
trapping. The 20-L sample was injected onto the
pre-column using Solvent A (5% AcN, 95% water,
and 0.05% TFA) at 5 L min1. The valve was
positioned so that the restriction capillary, connected
to the first T-piece, was blocked and all LC eluent was
flushed through the pre-column. The capillary on the
second T-piece was connected to waste. As a result,
no eluent was flushed through the analytical column
during this step. After trapping the sample, the
pre-column was flushed for 10 min with Solvent A at
the same flow. Next, the nano-valve was switched
with the intention that the pre-column was posi-
tioned in-line with the analytical column. Subse-
quently, the flow was raised in 1 min to 200 L
min1. Because with this valve position the restriction
capillary was connected to the waste line, a 1:1000
split was built into the system. Consequently, the
flow over the combined pre-column and analytical
column was 200 nL min1. After switching the nano-
valve, the gradient was started using a binary solvent
system: Solvent A as described above and Solvent B
(95% AcN, 5% water, and 0.05% TFA). The gradient
ran as follows: during the first 60 min Solvent B was
increased from 0 to 55%, afterwards Solvent B was
increased to 90% in 1 min and maintained at that
percentage for another 5 min. Finally, the system was
reconditioned by decreasing Solvent B to 0% in 1 min
and 0% B was maintained for 25 min. Afterwards, the
flow was returned in 1 min to 5 L min1 and the
nano-valve was switched to its original position.
Accordingly, the pre-column was positioned off-line
to the analytical column.
The Probot, a micro fraction collector, was started 15
min after injection. Using the Probot, the LC eluent, 200
nL min1, was mixed with 1.3 L min1 of MALDI
matrix (75% AcN, 25% water, 0.1% TFA, and 3 mg/mL
CHCA) and spotted on a blank MALDI target. Sample
was spotted, following a predefined 18  18 array,
every 20 s during 90 min, resulting per LC run in 270spots of 500 nL. The spotted MALDI target was mea-
sured off-line using MALDI-TOF/TOF.
MALDI-TOF/TOF
The 4700 proteomics analyzer (Applied Biosystems)
was used for all MALDI-TOF/TOF measurements. The
software was equipped with LC-MALDI features
wherein all spots were regarded as one large sample
spot set. Of each LC run, MS and MS/MS on the five
most abundant precursors were conducted in positive
ion mode. MS, used in reflectron mode, was used to
scan a m/z-range of 900–5000 with a fixed laser intensity
and 4500 laser shots per spectrum. Each spot was
calibrated by using external calibration spotted in a
separate sample spot. MS/MS was conducted using 1
kV collision energy and air as collision gas. MS/MS was
measured until a S/N ratio of 30 was obtained for at
least 20 peaks in the spectrum with an upper limit of
15,000 shots per spectrum. Data were analyzed using
the 4700 Explorer software.
Data Analysis
Solvent accessibilities of E9 lysine residues were based
on the X-ray data of E9 (accession code: 1FSJ) and
E9:Im9 complexes (accession codes: 1EMV [19], 1BXI
[32], and 1FR2 [19]) and calculated by using the soft-
ware program GETAREA 1.1 (www.scsb.utmb.edu/
getarea) [33]. We calculated both the total solvent
accessibility of the lysine side chains and the reactive
NZ atoms by using a radius of the water probe of 1.4 Å.
The average solvent-accessible surface areas of a lysine
side chain and a NZ atom in the “random coil” tripep-
tide Gly-Lys-Gly in an ensemble of 30 random confor-
mations are 164.5 and 45.0 Å2, respectively. Lysine side
chains were considered to be solvent exposed when the
area was larger than 82.25 Å2. Subsequent percentages
were calculated by dividing the observed area with the
total area of 164.5 or 45.0 Å2.
The MALDI-TOF spectra of proteins were analyzed
using the Data Explorer software (Applied Biosystems).
Data from the protein digests were analyzed with the
same software. Briefly, obtained peak lists were mass
fingerprinted by using an E9:Im9 protein database in
combination with the Mascot search engine (Matrix
Science, www.matrixscience.com). Peptides were
matched within 25 ppm and with optional modifica-
tions of oxidation on methionine-residues and acetyla-
tion on lysines and the N-terminus of the protein. For
LC-MALDI-data, the Peak Explorer software (Applied
Biosystems) was used to obtain a base peak chromato-
gram (BPC) and extracted ion chromatograms (XIC) of
precursor ions of the MS data. Quantification of precur-
sor ions was conducted by using the area of peaks
obtained from the XIC. Using the Analysis tab of the
Spot set window, MS/MS data could be searched for
the specific acetylated lysine immonium ion atm/z 126.1
Da, with a deviation of 0.1 Da to obtain an extracted ion
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abbreviated with EIC to distinguish with the extracted
ion chromatogram from the MS data. The obtained
LC-MS and LC-MS/MS data were further analyzed
using the MASCOT search engine.
Two types of relative quantification were performed.
First, normalization of the acetyl occupancy was ob-
tained for all peptides. This was achieved by analyzing
the peak areas of a certain peptide with all possible
occupancies, i.e., with none, one, two, etc. acetylations.
Then, the areas of all the different species of a peptide
were put as the fraction of the summed areas, followed
by normalization. An example of this calculation is
given in the results and discussion section for Figure 3.
Second, the percentage of acetylation for each lysine
was determined using the combined data of the MS/MS
spectra and the normalized quantification data. The
MS/MS spectra were used to determine the exact
position of acetylation, while the normalized quantifi-
cation data showed the ratio of the same peptide with
different numbers of acetylation. For example, when a
peptide had two lysines, the MS/MS data of the 1-fold
acetylated peptide provided information about the pre-
dominantly acetylated lysine. By combining this knowl-
edge with the fraction of non-acetylated, 1-fold acety-
lated and 2-fold acetylated peptide, the average
percentage of acetylation for each lysine could be de-
termined individually. The standard deviation (Stdev)
on this average percentage of acetylation for a lysine
was calculated using data from duplo samples. When a
specific lysine was retrieved in more than one peptides
stretch, the average percentage of acetylation per lysine
in the separate peptides was averaged and the standard
deviation (Stdev) was determined.
Results and Discussion
NHS-Ac is an Efficient Acetylating Reagent
The method employed here is based on the availability
of lysine residues for reaction with an acetylating re-
agent. As lysine residues have basic, charged side
chains, they are mainly found on the surfaces of pro-
teins, making them ideal targets to probe protein–
protein interaction surfaces.
Our first aim was to investigate the acetylating prop-
erties of NHS-Ac by assessing whether lysine residues are
affected by reaction with the reagent. To probe the inter-
action surface properly, full acetylation of all available
lysine residues in E9 within a short period of time is
required. Three different excess ratios of NHS-Ac (2.5, 25,
and 250 mol/mol lysine residues) on E9 were tested. To
elucidate which minimum reagent concentration resulted
in complete modification of E9, MALDI-TOF-MS was
employed. First, a spectrumwas obtained of a 1:1 mixture
of unmodified E9:Im9, which was used as a control
measurement. The [MH] (15,088 Da) and [M 2H]2
(7545 Da) signals of E9 were observed, as well as the [M
H] (9583 Da) signal of Im9 at their corresponding theo-retical average mass (Figure 2a). Upon modification with
a 250-fold excess of NHS-Ac for 3 min at room tempera-
ture, the [M 2H]2-signals of E9 shifted up inm/z to give
the distribution shown in Figure 2c. The most intense peak
in the distribution was observed at 7986 Da. The others
were all found at 21 Da m/z-intervals of this peak. This
corresponds to an overall mass difference of 42 Da, the
mass increase of an acetylated lysine. The average number
of modifications was calculated from the observed mass
as follows: (7986 Da–7545 Da)/21 Da  21 modifications.
This number corresponds closely to acetylation of every
lysine and the N-terminus. The same shift could be
observed for the [M  H]-signal of E9, however, the
resolution on this signal was not ideal to determine the
exact modification numbers (data not shown). Modifica-
tion of E9 with the two lower excesses did not lead to
complete lysine acetylationwithin 3min (data not shown).
Therefore, for further experiments, a 250-fold excess of
NHS-Ac and a reaction time of 3 min was used.
These results, obtained for the unbound E9, are in
close agreement with the crystal structure [19]. The
X-Ray structure revealed that all 20 lysines and the
N-terminus were calculated to be solvent accessible
(50 –100%) (Table 1). The percentage values were calcu-
lated with the GETAREA software as described in the
materials and methods. Three very similar crystallo-
graphic models of E9 in complex with Im9 (pdb-files:
1EMV, 1BXI, and 1FR2) were probed for solvent acces-
sibility of their lysine side chains and their NZ atoms.
The solvent accessibilities of the side chains were very
similar in the three models, whereas the accessibilities
of the NZ atoms were very different in each model (data
not shown). These differences in the accessibilities of
the NZ atoms are probably related to the dynamics of
the residues on the surface of E9 DNase. Therefore, we
used the values of the side chains as a measure for the
solvent accessibilities (Table 1).
MALDI-TOF-MS Analysis Reveals a Clear Im9
Induced Protection
Subsequently, acetylation of E9 was assayed in the
presence of Im9. Under identical conditions, the most
intense peak of the [M  2H]2 signals of E9 now
shifted up to m/z  7838 Da, corresponding to on
average 14 lysine modifications, instead of 21 (Figure
2d). These data indicate that Im9 reduces the acetyl
occupancy of several lysine residues in E9. Since Im9
also has six lysine residues, modification of Im9 alone
(Figure 2f) was compared with acetylation of Im9 in the
presence of E9 (Figure 2g). No significant effect of E9 on
the overall acetyl occupancy of Im9 lysines was ob-
served. This is in agreement with the NMR studies on
Im9 alone and Im9 in the presence of E9. These indi-
cated that binding E9 to Im9 does not cause a major
conformational change in Im9 and that lysine residues
of Im9 are not directly involved in the interaction with
E9 [22]. Unfortunately, no NMR structure could be
E9.
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complexity observed for E9 [34, 35].
The effect of transition-metal ions on the activity and
stability of E9 and the E9:Im9 complex have been studied
in detail [20, 23, 36]. In our experiments, we did not
observe any significant differential effect on the extent of
acetylation induced by the presence of Zn2 ions, both in
absence and presence of Im9 (data not shown). This is in
line with the fact that the crystal structures of the E9-Im9
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reliable and robust protease, its use was omitted here as
it can no longer cut after an acetylated lysine. Using
trypsin (data not shown), the proteolytic peptides be-
came very large, thereby reducing our resolution and
detection efficiency.
In the V8-digest of E9, 12 lysine-containing peptides
were identified by mass-fingerprinting, covering 11
lysines and 66% of the total protein sequence. The same
method yielded nine peptides for the chymotrypsin
digest, covering 17 lysines and the N-terminal amine
group with a sequence coverage of 78% (data not
shown). Combining the V8 and chymotrypsin data, 17
out of 20 lysines of E9 and the N-terminus were
covered, with 82% total sequence coverage. The amino
acid stretch between L23 and E46, containing K28, K41,
and K45, was not covered.
By comparing the E9 derived peptides in the pres-
ence and absence of Im9, more detailed information
about the area of E9 involved in the interaction became
evident. This is illustrated in Figure 3: a typical example
of a chymotryptic E9-peptide (84-99, 1805.97 Da) with
reduced acetylation induced by the binding to Im9. In
absence of Im9, the mass of the peptide was shifted 84
Da to 1890.0 Da, corresponding to complete acetylation
on both lysines. The lysines present in this peptide
became less accessible for acetylation upon Im9-bind-
ing, as the same peptide was now found in three forms;
unacetylated, singly acetylated, and doubly acetylated.
A semiquantitative analysis was performed by taking
the areas under the peak of the individual ions normal-
ized to the total area of all three ion peaks. This resulted
in 43% intensity allocated to unacetylated, 51% intensity
to singly acetylated, and only 6% to doubly acetylated.
Now the acetyl occupancy, or average modification
percentage, of this peptide was calculated at 32% ([0 ·
0.43  1 · 0.51  2 · 0.06]/2) in the presence of Im9 and
100% in the absence. This means a 68% protection for
this peptide towards the acetylating reagent upon Im9
binding. A similar semiquantitative analysis was con-
1800 1820 1840
50
1800 1820 1840
50
1800 1820 1840
50
SPTFPKNQQV
Unmodified +1
+42.0 Da<100
100
100 (a)
(b)
(c)
Figure 3. Peptide mass fingerprinting reveals
MALDI-TOF MS spectra of the E9 chymotr
Untreated, acetylated E9 in absence (b) and preducted for all other observed peptides. If a lysine wascovered in multiple peptides, for instance resulting
from the two different digests, the contribution was
averaged. It is clear from the spectra shown in Figure 3
that K89 and K97 are involved in the interaction of E9
and Im9. The V8 peptide 67-100 confirmed this as its
acetyl occupancy dropped from 100 to 44% in the
presence of Im9. In most detected peptides there were
two or more lysine residues present, hampering an
in-detail analysis by just MALDI-TOF-MS fingerprint-
ing. Such analysis alone does not enable to assess what
the individual contributions of the two isobaric species
present in Figure 3, acetylated at K89 or at K97 alone, to
the peak area at m/z 1847.98 Da are.
To address this issue, we chose for a LC-MALDI-
TOF/TOF approach, which allowed us to separate
isobaric species by their differential elution properties.
Subsequent sequencing by MS/MS can specifically
identify the structure of the isobaric species. Using this
approach, we observed that it was possible to estimate
the separate contributions of each isobaric species,
providing a high-resolution picture of, by the presence
of Im9 affected, lysine residues in E9. Also, all six lysine
residues of Im9 were covered using the two different
digests. However, no differentially modified peptides
were observed, reiterating that the acetyl occupancy of
Im9’s lysine residues was not affected by binding to E9
(data not shown). As mentioned earlier, this was as
expected, based on the available X-ray [19] and NMR
structures of Im9 [22] in absence and presence of E9.
Data Filtering Using Immonium Marker Ions
Efficiently Identifies Acetylated Peptides
By including an additional separation technique such as
nanoLC before MS, we aimed to separate isobaric
acetylated peptides, like the ones shown in Figure 3.
Adding the LC-approach to our analysis increased the
sequence coverage of E9 to 95%, likely due to less ion
suppression, and an important additional peptide con-
1860 1880 1900
1860 1880 1900
1860 1880 1900
KVY (84-99, 1806.0 Da)
tyl +2 Acetyl
+42.0 Da
<
ons within E9 with reduced acetyl occupancy.
peptide SPTFPKNQQVGGRKVY (84-99). (a)
(c) of Im9.GGR
 Ace
<<
regi
yptictaining K41 and K45 could be detected. Using nanoLC-
acetylated lysine.
990 SCHOLTEN ET AL. J Am Soc Mass Spectrom 2006, 17, 983–994MALDI-TOF/TOF, the obtained tandem MS data could
be filtered for specific detection of acetylated peptides
by using the specific immonium marker ion of an
acetylated lysine that is formed via collision induced
dissociation at m/z 126.1 Da (CID) [27–29]. This ion is a
further fragment ion induced by the loss of NH3 from
the acetylated lysine immonium ions at m/z 143.1.
However, the 126.1 Da marker ion is thought to be more
specific and 10 times more sensitive than the immo-
nium ion at m/z 143.1 [28]. Some of the advantages of
using this filtering procedure become evident when the
normalized base peak chromatograms (BPC) are com-
pared with the normalized extracted ion chromatogram
(EIC) of the 126.1 Da ions (Figure 4, upper two chro-
matograms). Overlaps of the BPC and the EIC could be
found for some peaks, e.g., spots 57, 70, and 76. How-
ever, more careful examination of the EIC between spot
42 and 54 showed that two acetylated precursor ions
were present in spots 44 and 46 that were obscured
under a larger coeluting peak in the BPC. Also, the
intense BPC peak in, e.g., spots 48 and 62, could be
discarded as acetylated peaks as they did not show any
signal in the 126.1 Da EIC. These examples show that
creating an EIC for acetylated lysines by its specific
marker immonium ion was an advantageous approach
to quickly filter out peptides of interest. The filtering
procedure increased both selectivity and sensitivity for
the determination of acetylated peptides. This is further
Table 1. Acetyl occupation of each lysine, as calculated from th
Methods section (left) and solvent accessibility of the lysine side
that showed major changes in occupancy or solvent accessibility
Lysine
Acetyl Occupancy by MS (%
E9
Avg Stdev Avg
NT 97.0 1.2 86.0
K4 97.0 1.2 86.0
K7 97.0 1.2 86.0
K10 97.0 1.2 86.0
K14 97.0 1.2 86.0
K16 97.0 1.2 86.0
K21 97.0 1.2 86.0
K28 a a
K41 11.6 1.4 13.8
K45 87.1 18.3 100.0
K48 97.8 1.8 90.1
K55 88.9 12.7 47.3
K63 100.0 0.0 47.2
K69 100.0 0.0 90.7
K76 100.0 0.0 10.5
K81 83.4 23.6 0.1
K89 100.0 0.0 54.4
K97 100.0 0.0 0.8
K105 96.4 5.4 90.5
K125 96.0 8.0 94.1
K134 94.7 9.1 95.5
aNot covered in digests.
bResidue not present in crystallographic model.illustrated in Figure 4 (lower two chromatograms)1 10 20 30 40 50 60 70 80
Spot number
XIC 1719.9/126.1 Da
XIC 1719.9
BPC
EIC 126.1 Da
Figure 4. Efficient selected filtering based on the acetylated
lysine marker ion. The LC-MALDI BPC chromatogram of the V8
digest of the acetylated E9:Im9 complex is shown in the top trace.
Below the EIC of the acetylation marker ion with m/z 126.1 Da is
shown, which directly identifies acetylated peptides present in the
complex mixture. The third trace shows the selected ion chromato-
gram of the precursor ion atm/z 1719.9 Da, which shows three ions
with different retention times. The bottom trace shows that with
further filtering by using both the 126.1 marker ion and the ion
chromatogram of the precursor ion at m/z 1719.9 Da, it can be
exclusively verified that only the precursor in spot 70 contained ane nanoLC-MALDI-TOF/TOF data as described in The Materials and
chains as calculated from the X-ray data (right). E9 lysine residues
upon Im9 binding are presented in bold
) Solvent Accessibility by X-Ray (%)
E9:Im9 E9 E9:Im9
Stdev (1FSJ.pdb) (1EMV.pdb)
2.4 99.7 b
2.4 67.0 61.2
2.4 75.0 84.1
2.4 72.5 65.5
2.4 93.7 74.8
2.4 65.8 66.6
2.4 75.9 80.7
68.2 64.4
10.3 58.6 48.6
0.0 57.2 56.5
6.2 90.8 88.9
5.6 56.9 61.4
4.0 67.6 70.8
2.8 46.5 80.2
3.5 50.5 45.7
0.1 61.2 50.5
10.4 100.0 50.2
0.5 55.3 9.5
13.3 66.8 62.4
3.4 55.5 57.2
2.4 100.0 b
991J Am Soc Mass Spectrom 2006, 17, 983–994 nanoLC MALDI MS/MS APPLIED TO E9:Im9 BACTERIOTOXINwhen zooming in on the peptide precursor ion with a
m/z of 1719.9  0.3 Da, corresponding to the rather
intense peak at spot 70 in the BPC. In the XIC of this
precursor ion, three peptide ion peaks could be ob-
served in the chromatogram (Figure 4). When the XIC
data were combined with the EIC data of 126.1 Da, one
peak remained, showing the increased selectivity and
sensitivity.
In a further analysis of the data, the acetylated
peptides identified by the filtering method were
matched to their original precursor mass. For each
identified peptide, an XIC for their precursor mass was
created and the corresponding MS/MS spectra were
then analyzed. From the XIC it is now possible to assess
different isobaric species by interpreting the MS/MS
spectra in each individual XIC peak. With this ap-
proach, it is possible to precisely localize the position of
the acetylated lysine within each peptide. An example
of this approach is depicted in Figure 5 for the precursor
ion with m/z 1845.8. This is the V8 peptide, FKSFD-
DFRKAVWEE (47-60), with one acetyl group attached.
The peptide contains two lysine residues and as a
consequence two peptides could have been formed,
whereby either K48 or K55 is acetylated. The XIC
showed that the species with m/z 1845.8 eluted in two
different LC-MALDI spots, 70 and 72 (Figure 5a, dashed
line). Next, the MS/MS spectra of the 1845.8 Da precur-
sor peptide ions present in spots 70 and 72 were
compared (see Figure 5b and c, respectively). Both
spectra contain the 126.1 Da immonium ion, but also
show clear differences. The intense y8- and y9-ions are
ideal for distinguishing these two isobaric species. In
the MS/MS spectrum of precursor 1845.8 in spot 70,
depicted in Figure 5b, the y8 ion was observed at an m/z
50 430
50%
100%
 Spot 70
F
126.1 marker ion
K R
50 430
50%
100%
Spot 72
126.1 marker ion
F
K
RSpot number
N
o
rm
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ed
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n
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n
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FKSFDDFRK
Ac
y8
b6
FKSFDDFRK
y8
b6
Ac
65 68 71 74
100%
XIC 1845.8
EIC 1064.4
EIC 1106.6 y8+Ac
 y8
(a) (c)
(b)
Figure 5. LC MALDI TOF/TOF enables the
peptides to pinpoint the locations of lysine acety
m/z 1845.8 Da, i.e., KSFDDFRKAVWEE (47-60) w
corresponding to precursor ion 1845.8 Da in LC
spot 70 spectrum was identified to originate from
spectrum corresponded to apparently 10-fold m
abundance was estimated based on the ion inten
[(a), thin line] ions in the two MS/MS spectra.1106.6, while the y8 ion in the spectrum of spot 72 wasobserved at m/z 1064.4, i.e., 42 Da lower (corresponding
to the mass of one acetyl group). This indicates that the
y8 ion of the peptide eluting in spot 70 contains an
acetyl group, while the one eluting in spot 72 does not.
This, and other fragment ions observed in the spectra,
define that the peptide in spot 70 originates from the
peptide acetylated at K55, while Figure 5c depicts the
spectrum of the peptide acetylated at K48. An EIC of the
two different y8 ions is depicted in Figure 5a as well.
When assuming that both peptides have similar ioniza-
tion efficiencies, it can be concluded from the EIC of
1064.4 Da (thick line) and 1106.4 Da (thin line) that the
K48-acetylated peptide has a 10-fold higher intensity
than the peptide with an acetyl on K55. This implies
that K48 has a high acetyl occupancy compared to K55,
which seems to be well protected upon Im9-binding.
The 67–100 Stretch Is Involved in the Interaction
with Im9
The MALDI-TOF mass fingerprint indicated that the V8
peptide 67-100 (LSKNLNPSNKSSVSKGYSPFTPKN-
QQVGGRKVYE) harbors interesting information about
the interaction between E9 and Im9. This peptide was
recovered in its completely acetylated form when Im9
was not present (data not shown). In contrast, in the
presence of Im9, this peptide contained in between zero
and four acetyl groups. Tandem mass spectra of all four
acetylated species of this peptide were considered. To
our surprise, we observed a strict order of acetylation
for the five different lysines present in this peptide, i.e.,
no significantly abundant isobaric species could be
observed for this peptide. From the MS/MS-spectrum
Mass (m/z)
0 1190 1570 1950
Y7+Ac
B8
Y9+Ac
Y8+Ac
B13+H2O+Ac
Y13+Ac
[M+H]+
0 1190 1570 1950
Y7
Y8
B8+Ac B9+Ac
Y9
A11+Ac
Y13+Ac
B13+H2O+Ac
[M+H]+
E
E
idation of the exact structure of two isobaric
n. (a) Extracted ion chromatogram of ions with
e acetyl group (dashed line). (b) MS/MS spectra
LDI spot 70 and (c) in LC-MALDI spot 72. The
FKSFDDFRK(Ac)AVWEE ion, while the spot 72
bundant FK(Ac)SFDDFRKAVWEE ion. Relative
in the EIC of the y8 [(a), thick line] and y8Ac81
81
Y6
AVWE
AVWE
eluc
latio
ith on
-MA
the
ore a
sityof the singly acetylated peptide, we determined that
t pro
992 SCHOLTEN ET AL. J Am Soc Mass Spectrom 2006, 17, 983–994K69 was the uniquely acetylated residue (data not
shown). K89 was found to be the next residue to be
acetylated in the doubly acetylated peptide (Figure 6a).
The subsequent lysine found to be acetylated was K76
(Figure 6b). The peptide with four acetyl groups was
modified at K69, K76, K89, and K97 (data not shown).
The fifth and last lysine, K81, was never found to be
acetylated in the presence of Im9. Combining the nor-
malized quantification data and the information ob-
tained from the MS/MS spectra, the percentage of
acetylation of each lysine could now be determined
(Table 2). An overview of the nanoLC-MALDI-TOF/
TOF derived acetyl occupancy of each individual lysine
residue is given in Table 1. All lysines between 41 and
134 could be individually scored for their acetyl occu-
pancy. The intensity of chymotryptic N-terminal pep-
tide 1-22 was too low to obtain reliable MS/MS data
and therefore the individual lysines could not be scored
for this N-terminal stretch. However, this region does
not seem to be affected by Im9 binding. Also depicted in
Table 1 are the solvent accessibilities of each lysine
residue side chain, as derived from the X-ray data of E9
and E9 bound to Im9 (accession codes 1FSJ and 1EMV
[19], respectively) by using the GETAREA software.
LC-MALDI TOF/TOF Data Provides New Insight
on the E9:Im9 Interaction
The derived experimental data on the acetyl occupancy
of lysine residues in E9 were compared with the solvent
accessibilities obtained from the X-ray structural mod-
els of E9 and the E9:Im9 complex (Table 1, Figure 7).
The lysine occupancy and solvent accessibility percent-
ages were sorted in five distinct categories between 0
50 740 1430
50%
100%
50 740 1430
50%
100%
Y1
Y13
Y13
Y11
Y10
Y9
Y8Y7
Y11-NH3
LSK
Ac
LSK
Ac
Y
Y13+A
Y11
Y10
Y9
Y7
Y11-NH3
x0.1
126.1 marker ion
x0.3
126.1 marker ion
(a)
(b)
Figure 6. Consecutive acetylation events on
TOF/TOF MS/MS spectrum of the 2-fold acety
(Ac)NQQVGGRKVYE (MW  3822.7) (b) M
acetylated peptide LSK(Ac)NLNPSNK(Ac)SSVS
Identifying the exact location of the acetylation in
acetylation events and, thus, the order of solvenand 100% and color coded into the model (Figure 7).Our MS data show that lysine residues K55, K63, K76,
K81, K89, and K97 become considerably more protected
against acetylation upon interaction with Im9. The
X-ray model of the structure of the E9:Im9 complex
shows that the interaction surface between E9 and Im9
spans primarily the amino acids 72–98 of E9. In fact, the
two lysine residues K89 and K97 are directly involved
2120 2810 3500
2120 2810 3500
Y25+Ac
Y16+Ac
Y16
SNKSSVSKGYSPFTPKNQQVGGRKVYE
y25
b9
Ac
y13
b21
SNKSSVSKGYSPFTPKNQQVGGRKVYE
y25
b9
Ac
y13
b21
Ac
Y25+2AcY16+Ac
ptide 67-100 in presence of Im9. (a) MALDI
peptide. LSK(Ac)NLNPSNKSSVSKGYSPFTPK-
I TOF/TOF MS/MS spectrum of the 3-fold
SPFTPK(Ac)NQQVGGRKVYE (MW  3864.8).
e peptides enables the elucidation of consecutive
tection of the individual sites upon E9 binding.
Table 2. Percentage of acetyl occupancy on each individual
lysine residue in the partial E9 sequence 67-100
(SKNLNPSNKSSVSKGYSPFTPKNQQVGGRKVYE) in the
presence of Im9, as calculated from the nanoLC-MALDI-TOF/
TOF data. See data analysis in the experimental section for
calculation procedures
A) Quantification is given in column 3 and in column 4 the
acetylated lysines are indicated
Species
Number of
Ac-groups
Acetyl
occupancy
(%) Acetylated lysine
I 0 0.73 -
II 1 31.0 K69
III 2 48.8 K69, K89
IV 3 11.7 K69, K89, K76
V 4 1.14 K69, K89, K76, K97
VI 5 0 K69, K89, K76, K97,
K81
B) Percentage of acetylation for each lysine
Lysine Present in:
Percentage of
acetylation
K69 II-V 92.7
K89 III-V 61.7
K76 IV-V 12.9
K97 V 1.144
+Ac
NLNP
NLNP
14+Ac
c
E9-pe
lated
ALD
KGY
thesK81 - 0
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forms a hydrogen bond interaction with the side chain
of E41 of Im9, whereas the side chain of K97 coordinates
towards the side chain of D51 of Im9. These interactions
protect the two residues from solvent (Table 1). Our MS
data on K89 and K97 are fully in line with these data, as
they show a significant decrease in acetyl occupancy of
K89 and K97 upon binding to Im9. The lysines K81 and
K76 are also in the peptide stretch 72–98, but are,
according to the X-ray models, not directly involved in
the interaction with Im9. In addition, the model suggest
that binding to Im9 does not influence the solvent
accessibility of these two residues. However, our MS
data clearly indicate that Im9 interaction lowers the
acetyl occupancy of the two lysines significantly from
fully reacted in the free E9 to nearly fully protected
from our reagent in the Im9 bound state (Table 1). K76
and K81 are positioned in an -helical domain in close
proximity to Im9; therefore, we speculate that binding
to Im9 induces changes in the dynamics of K76 and K81
such that they become protected for the reagent. Alter-
natively, it may also indicate that E9 in the E9:Im9
Figure 7. Graphical representation to compare acetyl occupancy
MS-data with X-Ray solvent accessibility data. Solvent accessibil-
ity data as extracted from the X-ray data of E9 and E9:Im9 using
the program GetArea are given on the left (also see Table 1). On
the right, the experimental data as obtained in this study on the
lysine solvent accessibilities are given (see also Table 1). The
amount of acetyl occupancy/solvent accessibility is given using a
color scheme, whereby green indicates 0–20%, beige 20–40%,
yellow 40–60%, orange 60–80%, and red 80–100% occupancy/
accessibility.complex is partly present in a conformation differentfrom the one described in the X-ray model. This is not
unexpected as solution-phase NMR data have indicated
high structural dynamics throughout the whole struc-
ture of E9 in both free and Im9-bound state [34, 35].
Unfortunately, the complete NMR structure of E9 could
not be solved due to these high structural dynamics.
We also observed that K55 and K63, which are both
present in an -helix, show a decreased lysine occu-
pancy upon binding to Im9 (Table 1). These changes in
accessibility were also not predicted from the X-ray
structures. The rationale for the decreased accessibility
is not clear, as both residues do not form a direct
interaction with Im9. However, it is interesting to note
that K55 is known to form a hydrogen bond with the
dsDNA substrate in the structural homologue E7 [37].
Upon binding of Im9 to E9, the interaction with dsDNA
is inhibited. The principle behind this inhibition is not
well understood; however, it can be speculated that the
interaction with Im9 also induces conformational dy-
namics in some amino acid residues, such as in K55 and
K63, to hamper these residues to interact with dsDNA.
A final intriguing result is the low acetyl occupancy
of K41 both in absence and presence of Im9. As this
residue is far from the Im9 interaction surface and the
catalytic center, we cannot give a rationale for the low
occupancy of this residue. The low accessibility of this
residue is in disagreement with the X-ray model (see
Table 1), reinstating that the solution-phase structure of
E9 in the presence and absence of Im9, might to some
extent be different.
Conclusions
The combination of lysine acetylation, proteolytic diges-
tion, and MALDI-TOF/TOF tandemmass spectrometry
can be successfully applied to study protein–protein
interaction surfaces. When nanoLC is used in combina-
tion with MALDI-TOF/TOF, data resolution can be
increased and single amino acid resolution may be
obtained. Extra selectivity and sensitivity for peptides
that contain acetylated lysines can be obtained by
filtering the data for the MS/MS product withm/z 126.1,
a specific immonium ion of acetylated lysines. The
applicability of this approach was demonstrated using
the E9:Im9 complex. Our data clearly revealed that six
lysine residues in the E9 protein become less accessible
upon binding of Im9: K55, K63, K76, K81, K89, and K97.
K76, K81, K89, and K97 are located at the protein–
protein binding interface. The X-ray structure model
predicts that K89 and K97 are directly involved in the
binding with acidic amino acid residues of Im9. Our
data suggested that K81 and K76 are involved in the
E9:Im9 interaction, or at least in very close proximity to
Im9. The other lysine residues with a reduced accessi-
bility are K55 and K63, of which K55 is involved in
dsDNA binding in the E7 homologue enzyme. In the
E7:Im7 complex, Im7 binding physically blocks one of
the major dsDNA binding sites [37]. Due to high
homology among the colicins, the same situation is
994 SCHOLTEN ET AL. J Am Soc Mass Spectrom 2006, 17, 983–994expected for E9:Im9. It may also be hypothesized that
the conformational dynamics of amino acids in the
DNA interacting region change upon Im9 binding,
thereby further hampering interaction with dsDNA.
In brief, the presented approach can be used to probe
protein–protein interactions in moderate detail. This
may be used as complementary data to already avail-
able structural models from X-ray crystallography. As it
is a solution-phase approach, additional information
may be obtained reflecting specific solution-phase con-
formations.
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